Swiss multicenter study evaluating the efficacy, feasibility and safety of peginterferon-alfa-2a and ribavirin in patients with chronic hepatitis C in official opiate substitution programs

Fried R, Frei M, Schönbucher P, Kölliker C, Broers B, Isler M, Herold M, Schmid P, Oppliger R, Seidenberg A, Monnat M, Huber M. Swiss multicenter study evaluating the efficacy, feasibility and safety of peginterferon-alfa-2a and ribavirin in patients with chronic hepatitis C in official opiate substitution programs. Digestion 2008; 78:123-30.